CXGEF yields 7.80% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CXGEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CXGEF + PFE for your $10,000?
Computer And Technologies Holdings Limited, an investment holding company, provides information technology (IT) solutions for enterprises, multinational corporations, and government organizations in Hong Kong, Mainland China, and internationally. It operates in three segments: Application Services, Solutions and Integration Services, and Investments. The Application Services segment primarily provides enterprise applications software and e-business services for enterprises, including the provision of enterprise application software with implementation and ongoing support services; and government electronic trading services, cloud services, and other related value-added services. Its Solutions and Integration Services segment offers IT solutions implementation and application software development; provision of IT and related operation/infrastructure outsourcing services; business process outsourcing services; and IT systems and network infrastructure with related design, implementation, and ongoing support services. The company's Investments segment engages in various types of investing activities, such property investment for rental income and/or for capital appreciation, and treasury investment in securities. The company also provides system and network integration services; computer support and programming services; products, solutions, and consulting services for cyber intelligence and security; enterprise information management, retail management, and procurement management software products; and human resources management services, as well as sale of computer networks and system platforms, provision of training, and implementation and maintenance of software services. Computer And Technologies Holdings Limited was founded in 1991 and is headquartered in Hong Kong, Hong Kong.
Full CXGEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.